// App-Quantinova.ai

5021 : Copy number profiles of primary tumors for risk stratification of advanced prostate cancer: A biomarker study embedded in the multicenter STAMPEDE trial.

Researchers

Presenter

  • Emily Grist

Principal Investigators

  • Stefanie Friedrich

  • Christopher D. Brawley

  • Larissa Mendes

  • Sharanpreet Lall

  • Leila Zakka

  • Sara Santos Vidal

  • Nafisah B. Atako

  • Malissa Richmond

  • Sofeya Ishaq

  • Alex Hoyle

  • Adnan Ali

  • Noel W. Clarke

  • Nicholas D. James

  • Mahesh K. B. Parmar

  • Daniel Berney

  • Paolo Cremaschi

  • Louise C. Brown

  • Gerhardt Attard

Medical Centers

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Queen Mary University of London, London, United Kingdom

  • MRC Clinical Trials Unit, UCL, London, United Kingdom

  • The Christie NHS Foundation Trust (retired), Manchester, United Kingdom

  • University of Manchester, Manchester, United Kingdom

  • GenitoUrinary Cancer Research Group, The Christie and Salford Royal Hospitals, Manchester, United Kingdom

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom

  • Bart's Cancer Institute, London, United Kingdom

  • MRC Clinical Trials Unit, UCL, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved